Overall Fundamental outlook

Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.

Revenue projections:

Revenue projections for PGHH
Revenue projections for PGHH

Procter & Gamble Hygiene and Health Care Limited is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.

Financial Ratios:

currentRatio 1.411000
forwardPE 51.093582
debtToEquity 0.272000
earningsGrowth 0.173000
revenueGrowth 0.101000
grossMargins 0.630850
operatingMargins 0.289380
trailingEps 220.100000
forwardEps 292.530000

PGHH's current ratio, being 1.411, means the company is well-positioned to meet its short-term debt obligations. This reflects PGHH's strong liquidity, as its cash reserves and current assets provide more than enough coverage for its immediate liabilities.
Procter & Gamble Hygiene and Health Care Limited's high forward PE suggests the stock may be overvalued, which could prevent further price gains and lead to a correction. This parameter should be carefully evaluated in context with other fundamental data to ensure a balanced view.
Procter & Gamble Hygiene and Health Care Limited's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that Procter & Gamble Hygiene and Health Care Limited will continue to grow its operations, driven by increasing profits and revenue.
Procter & Gamble Hygiene and Health Care Limited's positive gross and operating margins indicate the company's ability to operate profitably. These margins reflect strong financial management, with efficient cost control contributing to sustained profitability and a solid financial outlook.
Procter & Gamble Hygiene and Health Care Limited's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that Procter & Gamble Hygiene and Health Care Limited is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for PGHH
Price projections for PGHH



Recommendation changes over time:

Recommendations trend for PGHH
Recommendations trend for PGHH


Analysts' buy bias toward Procter & Gamble Hygiene and Health Care Limited suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, Procter & Gamble Hygiene and Health Care Limited is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.